| Monogenic and polygenic determinants of sarcoma risk: an international genetic study ML Ballinger, DL Goode, I Ray-Coquard, PA James, G Mitchell, ... The Lancet Oncology 17 (9), 1261-1271, 2016 | 221 | 2016 |
| Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer MB Loughrey, PM Waring, A Tan, M Trivett, S Kovalenko, V Beshay, ... Familial cancer 6, 301-310, 2007 | 203 | 2007 |
| Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes EA Lobb, PN Butow, A Barratt, B Meiser, C Gaff, MA Young, E Haan, ... British Journal of Cancer 90 (2), 321-327, 2004 | 167 | 2004 |
| Genetic professionals' reports of nondisclosure of genetic risk information within families A Clarke, M Richards, L Kerzin-Storrar, J Halliday, MA Young, ... European Journal of Human Genetics 13 (5), 556-562, 2005 | 153 | 2005 |
| Optimal Selection of Individuals for BRCA Mutation Testing: A Comparison of Available Methods PA James, R Doherty, M Harris, BN Mukesh, A Milner, MA Young, C Scott Journal of Clinical Oncology 24 (4), 707-715, 2006 | 139 | 2006 |
| Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field T Yanes, MA Young, B Meiser, PA James Breast Cancer Research 22 (1), 21, 2020 | 131 | 2020 |
| Psychological impact of genetic testing for hereditary non‐polyposis colorectal cancer B Meiser, V Collins, R Warren, C Gaff, DJB St John, MA Young, K Harrop, ... Clinical genetics 66 (6), 502-511, 2004 | 99 | 2004 |
| A multicenter study of supportive‐expressive group therapy for women with BRCA1/BRCA2 mutations MJ Esplen, J Hunter, M Leszcz, E Warner, S Narod, K Metcalfe, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 92 | 2004 |
| Tailoring communication in consultations with women from high risk breast cancer families EA Lobb, PN Butow, B Meiser, A Barratt, C Gaff, MA Young, J Kirk, ... British Journal of Cancer 87 (5), 502-508, 2002 | 90 | 2002 |
| A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk CE Wakefield, B Meiser, J Homewood, M Peate, A Taylor, E Lobb, J Kirk, ... Breast cancer research and treatment 107, 289-301, 2008 | 79 | 2008 |
| Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications? LA Keogh, CM Van Vliet, DM Studdert, JA Maskiell, FA Macrae, ... Medical Journal of Australia 191 (5), 255-258, 2009 | 77 | 2009 |
| Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility SM Rowley, L Mascarenhas, L Devereux, N Li, KC Amarasinghe, ... Genetics in Medicine 21 (4), 913-922, 2019 | 62 | 2019 |
| Women’s preferences and consultants’ communication of risk in consultations about familial breast cancer: impact on patient outcomes EA Lobb, PN Butow, B Meiser, A Barratt, C Gaff, MA Young, J Kirk, ... Journal of Medical Genetics 40 (5), e56-e56, 2003 | 61 | 2003 |
| Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review AM Willis, SK Smith, B Meiser, ML Ballinger, DM Thomas, MA Young Clinical genetics 92 (2), 121-133, 2017 | 58 | 2017 |
| Familial adenomatous polyposis in a 5 year old child: a clinical, pathological, and molecular genetic study. S Distante, S Nasioulas, GR Somers, DJ Cameron, MA Young, SM Forrest, ... Journal of medical genetics 33 (2), 157-160, 1996 | 58 | 1996 |
| Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer Y Antill, J Reynolds, MA Young, J Kirk, K Tucker, T Bogtstra, S Wong, ... European journal of cancer 42 (5), 621-628, 2006 | 54 | 2006 |
| Uptake of Offer to Receive Genetic Information about BRCA1 and BRCA2 Mutations in an Australian Population-Based Study LA Keogh, MC Southey, J Maskiell, MA Young, CL Gaff, J Kirk, KM Tucker, ... Cancer Epidemiology Biomarkers & Prevention 13 (12), 2258-2263, 2004 | 51 | 2004 |
| G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history T Anagnostopoulos, M Pertesi, I Konstantopoulou, S Armaou, S Kamakari, ... Breast cancer research and treatment 110, 377-385, 2008 | 50 | 2008 |
| Screening behavior in women at increased familial risk for breast cancer YC Antill, J Reynolds, MA Young, JA Kirk, KM Tucker, TL Bogtstra, ... Familial cancer 5, 359-368, 2006 | 50 | 2006 |
| Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? KA McBride, ML Ballinger, TE Schlub, MA Young, MHN Tattersall, J Kirk, ... Familial cancer 16, 423-432, 2017 | 48 | 2017 |
